Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


2nd Inflammatory & Immunological Biomarkers

20 Mar 2013 - 22 Mar 2013 - Hilton San Francisco Financial District



Bookmark and Share


GTC is proud to present the 2nd Inflammatory & Immunological Biomarkers as part of our Biomarker Summit 2013, to be held on March 20-22, 2013 in San Francisco, California. This conference will discuss a wide range of issues in the biomarker field specific to inflammatory and immunological therapeutic areas. Topics such as novel approaches to biomarker discovery, enabling technologies, regulatory and reimbursement trends and the development of companion diagnostics will be discussed. Specific disease areas include cardiovascular disease, metabolic diseases, arthritis, autoimmune diseases, kidney / renal disease and inflammatory bowel disease. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Below is an agenda outline for this conference:

March 20th

Plenary Keynote Session

March 21st-22nd

Breakout: Inflammatory / Immunological Biomarkers

Inflammation and related Biomarkers in Cardiovascular Disease

Biomarkers of Inflammation in Kidney / Renal Disease

Inflammation in Metabolic Diseases

- Diabetes

- Obesity

Biomarkers of Autoimmune Diseases

- Rheumatoid arthritis

- SLE

Biomarkers of Inflammatory Bowel Disease

- Crohnes

- Ulsarative Colitis

Biomarkers in Respiratory Diseases

Molecular Pathways Linking Inflammation and Cancer

Mar 22nd

 

General Session

Regulatory & Reimbursement Updates in Biomarker Development

+ Panel Discussion

Companion Diagnostics Development & Partnering Strategies

+ Panel Discussion



Further information
Scientific News
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
Protein Teams Activate T-Cells
Caltech researchers have discovered T-cell genetic switching is controlled by four proteins acting in a multi-tiered fashion.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.
Go-Between Immune Cell is Key to Priming the Body’s Fight Against Cancer
‘Antigen-presenting cell’ activates T cells by alerting them to the presence of tumors.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!